tiprankstipranks
Intensity Therapeutics, Inc. (INTS)
NASDAQ:INTS
US Market

Intensity Therapeutics, Inc. (INTS) Financial Statements

253 Followers

Intensity Therapeutics, Inc. Financial Overview

Intensity Therapeutics, Inc.'s market cap is currently $14.45M. The company's EPS TTM is $1.69; its P/E ratio is -11.99; Intensity Therapeutics, Inc. is scheduled to report earnings on March 27, 2026, and the estimated EPS forecast is $-1.34. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ -26.00K$ 0.00$ -147.00K$ 0.00$ 0.00
Operating Income$ -11.97M$ -16.59M$ -8.32M$ -7.55M$ -8.01M
EBITDA$ -11.97M$ -16.27M$ -10.09M$ -7.50M$ -7.88M
Net Income$ -11.61M$ -16.27M$ -10.54M$ -7.58M$ -7.90M
Balance Sheet
Cash & Short-Term Investments$ 11.92M$ 2.59M$ 14.78M$ 1.31M$ 4.54M
Total Assets$ 14.10M$ 4.78M$ 17.30M$ 1.76M$ 5.22M
Total Debt$ 110.00K$ 138.00K$ 158.00K$ 4.49M$ 2.34M
Net Debt$ -11.81M$ -2.45M$ -8.40M$ 3.18M$ -2.20M
Total Liabilities$ 2.23M$ 1.86M$ 4.13M$ 16.86M$ 13.90M
Stockholders' Equity$ 11.88M$ 2.92M$ 13.16M$ -15.10M$ -8.68M
Cash Flow
Free Cash Flow$ -9.23M$ -15.22M$ -7.21M$ -5.48M$ -6.83M
Operating Cash Flow$ -9.23M$ -15.22M$ -7.21M$ -5.48M$ -6.83M
Investing Cash Flow$ 0.00$ 6.35M$ -6.02M$ 0.00$ 0.00
Financing Cash Flow$ 18.56M$ 2.90M$ 20.47M$ 2.25M$ 2.05M
Currency in USD

Intensity Therapeutics, Inc. Earnings and Revenue History

Intensity Therapeutics, Inc. Debt to Assets

Intensity Therapeutics, Inc. Cash Flow

Intensity Therapeutics, Inc. Forecast EPS vs Actual EPS